Abstract. Thymidine phosphorylase (TP) is an enzyme involved in reversible conversion of thymidine to thymine. TP is identical to an angiogenic factor, pletelet-derived endothelial cell growth factor (PD-ECGF) and the expression levels of TP in a variety of malignant tumors were higher than the adjacent non-neoplastic tissues. To investigate the molecular basis for the effect of TP on the metabolic process and the anticancer effect of 5-fluorouracil (5-FU), human gastric carcinoma AZ521 cells and epidermoid carcinoma KB cells were transfected with TP cDNA, and AZ521/TP and KB/ TP were cloned. AZ521/TP and KB/TP cells overexpressed TP and were more sensitive to 5-FU than the counterpart parental cells. TPI, a newly synthesized inhibitor for TP (Ki=2.36x10 -9 M), decreased the sensitivity to 5-FU of the TP expressing cells but not of the parental cells. 5-Formyltetrahydrofolate (leucovorin; LV) stabilized the complex of thymidylate synthase (TS) and 5-fluoro-deoxyuridinemonophosphate (FdUMP), increased the sensitivity to 5-FU of TP expressing AZ521 cells, but not of the parental cells. The levels of FdUMP in TP expressing cells were significantly higher than in parental cells and TPI considerably decreased FdUMP to the level comparable to that in the parental cells. 5-FU increased the expression of early growth response protein-1 (Egr-1) and an angiogenesis inhibitor, thrombospondin-1 (TSP-1), in KB/TP cells but only slightly in KB/CV cells, if any. TPI attenuated the induction of Egr-1 and TSP-1 mRNA by 5-FU, while LV increased the expression of Egr-1 and TSP-1 mRNA in KB/TP cells. These findings demonstrate that the TP has a principal role in the production of FdUMP and the enhanced responses to 5-FU by leucovorin in TP-overexpressing KB and AZ521 cells, and FdUMP but not FUTP is implicated in the induction of Egr-1 and TSP-1 in KB cells.
Introduction
Thymidine phosphorylase (TP) catalyzes the reversible phosphorolysis of thymidine, deoxyuridine, and their analogues to their respective bases and 2-deoxyribose-1-phosphate (1) (2) (3) . It also catalyzes deoxyribosyltransfer from one deoxynucleotide to another base, to form a second deoxyuridine (4) (5) (6) . Recent studies showed that TP is expressed in a wide variety of solid tumors (7) (8) (9) (10) (11) (12) (13) , but the role of TP in tumor proliferation was unknown. We have found that TP is identical to an angiogenic factor, platelet-derived endothelial cell growth factor (PD-ECGF), and the enzymatic activity of TP is need for the angiogenesis by TP (14) (15) (16) . TP is also considered to activate some pyrimidine antimetabolites (17) (18) (19) . 5-Fluorouracil (5-FU) was developed as a potential anti-tumor drug (20) , and reportedly activated through three alternative routes. It may be converted to FUMP either directly by orotate phosphoribosyltranferase or by the sequential actions of uridine phosphorylase and uridine kinase. FUMP may be converted to FUDP and then to FUTP, INTERNATIONAL JOURNAL OF ONCOLOGY 36: 1193 -1200 , 2010 The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells which is incorporated into RNA, thus interfering with its synthesis and nuclear processing. Alternatively, FUMP is converted to FUDP by pyrimidine kinase and converted to FdUDP by ribonucleotide reductase. FdUDP is then converted to 5-fluoro-deoxyuridine-monophosphate (FdUMP) which inhibits thymidylate synthetase and hence DNA synthesis. Another route of 5-FU activation to FdUMP is catalyzed by TP and thymidine kinase. Thymidylate synthase (TS) (EC 2.1.1.45), which converts deoxyuridine monophosphate (dUMP) to thymydilate, plays an essential role in the synthesis of DNA. Inhibition of TS by 5-FU is mediated by the formation of a stable ternary complex between the active anabolite FdUMP, the target enzyme TS, and the cofactor 5,10-methylenetetrahydrofolates (5,10-CH 2 H 4 PteGlun) (21, 22) . Recently, we have indicated that 5-FU activated p38 MAPK and then upregulated Egr-1 expression, resulting in the expression of an endogenous antiangiogenic factor, TSP-1. The induction of TSP-1 was suggested to be implicated in the antitumor effect 5-FU (23) . However, the molecular basis for the induction by 5-FU is not fully understood. In this study, we examined whether TP is needed for the induction of TSP-1 by 5-FU, and which of the two cytotoxic metabolites of 5-FU, FUTP and FdUMP, is involved in the induction of Egr-1 and TSP-1.
Materials and methods
Chemicals. 
Transfection of PD-ECGF cDNA into AZ521 and KB cells.
PD-ECGF full length cDNA was kindly provided by Dr K. Miyazono and Dr C.H. Heldin (Ludwig Institute for Cancer Research, Uppsala, Sweden). A KpnI-EcoRI fragment from pPL8 that encompassed the PD-ECGF coding region was cloned between the KpnI and EcoRI restriction sites of pT7T318U (Pharmacia, Uppsala, Sweden). An XbaI-EcoRI fragment from pT7T318U was then cloned between the NheI and EcoRI restriction sites of the expression vector pBK-RSV (Stratagene, La Jolla, CA). The expression vector encoding PD-ECGF cDNA (RSV/TP) was transfected into AZ521 and KB cells by electroporation (24) . After selection with Geneticin, expression of PD-ECGF/TP in each clone was determined by immunoblotting using an anti-PD-ECGF/ TP monoclonal antibody. TP-positive clones transfected with RSV/TP (AZ521/TP and KB/TP cells) and TP-negative clones (AZ521 and KB cells) were further analyzed.
Preparation of cell lysate. Cells were lysed in 10 mM Tris-HCl (pH 7.5) by rapid freeze-thawing in liquid nitrogen. The lysates were centrifuged at 15,000 x g for 20 min at 4˚C and the supernatants were resolved by electrophoresis (25) . Protein concentrations were determined by the method of Bradford (26) .
Immunoblot analysis. The proteins in the supernatants were separated using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) according to the method of Laemmli (27) . Proteins in the gel were electrophoretically transferred to a sheet of polyvinylidene difluoride (PVDF) membrane (Immobilon-P transfer membrane; Millipore, Bedford, MA) with Bio-Rad Transblot SD as described (28) . The membranes were then reacted with primary antibodies against TP, Egr-1, TSP-1 and poly (ADP-ribose) polymerase (PARP). After incubation, membranes were washed and incubated with anti-mouse or anti-rabbit secondary antibodies. The membranes were developed using the enhanced chemiluminescence Western blotting detection system (Amersham, Buckinghamshire, UK).
Quantitation of drug sensitivity. The sensitivity of parental and transfected cells to agents were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay as described (29 Incorporation of fluoropyrimidines into RNA. Parental and transfected cells were suspended at 5x10 5 cells and incubated with or without 100 μM TPI overnight. After a 24-h incubation, cells were exposed to 80 nM [ 3 H]5-FU for 12 h. Total cellular RNA was isolated and purified with the TRIzol reagent (Life Technologies, Rockville, MD) using phenol/ chloroform followed by isopropanol precipitation as recommended by the manufacturer. The RNA pellet was dissolved with 22 ml TE and quantitated by UV absorbance at 260/280 nm. Radioactivity in an aliquot of the elusion was determined.
RT-PCR methods. Total cellular RNA was extracted using TRIzol reagent according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). RT-PCR was performed with the SuperScript One-Step RT-PCR system and gene-specific primers according to the manufacturer's instructions (Invitrogen). Reaction mixtures containing total RNA (500 ng of each), 0.2 mM dNTPs, 0.2 μM of each primer, enzyme mixture including SuperScript II RT, platinum Taq DNA polymerase, and 1X buffer with 1.2 mM MgSO 4 were maintained at 50°C for 20 min, then at 94°C for 2 min, and PCR was performed as follows: the PCR profile was 30 cycles at 94˚C for 15 sec, 55°C for 30 sec, and 70°C for 30 sec. The primers for RT-PCRs were designed based on human sequences in GenBank. These sequences used the following primers: TSP-1, 5'-AGAATGCTGTCCTCGCTGTT-3' (sense), and 5'-TTTCTTGCAGGCTTTGGTCT-3' (antisense); GAPDH, 5'-AGAACATCATCCCTGCCTCTACTGG-3' (sense) and 5'-AAAGGTGGAGGAGTGGGTGTCGCTG-3' (antisense).
Quantitative real-time PCR.
The expression levels of TSP-1 mRNA were determined by real-time PCR (PRISM 7900HT, Applied Biosystems) using SYBR Green I (Takara, Ohtsu, Japan) technology following the manufacturer's protocol. The sequence of the primer sets used for this analysis is as follows: These sequences used the following primers:
Caspase 3 activity. Cells were lysed in buffer A [25 mM Hepes (pH 7.4), 5 mM EDTA, 2 mM DTT and 2 mM APMSF, 10 μg/ml pepstatin A and 10 μg/ml leupeptin]. The lysates were clarified by centrifugation and the supernatants were used for enzyme assays. Enzymatic reactions were carried out in buffer A containing 100 μg of protein and 50 μM Ac-DEVD-AMC as substrates for caspase 3. The reaction mixtures were incubated at 30°C for 60 min. Caspase 3 activity was measured at an excitation wavelength of 360 nm and an emission wavelength of 460 nm using a FP750 microplate fluorescence reader (Jasco, Tokyo, Japan). The sensitivity of the enzyme assays using AMC as caspase substrates was equivalent to 7-amino-4-methylcoumarin in purified systems.
Results
Expression level of TP. We examined the expression levels of TP in human gastric carcinoma AZ521 cells, human epidermoid carcinoma KB cells, and the cells transfected with TP (AZ521/TP and KB/TP) by immunoblot analysis using an anti-TP monoclonal antibody. AZ521/TP and KB/TP cells expressed TP, but parent AZ521 and KB cells did not express detectable amount of TP (Fig. 1) . AZ521/TP and KB/TP cells had high TP activities, but TP activity was not detected in AZ521 and KB cells (data not shown).
Drug sensitivity of parental and TP expressing cell lines. TP is involved in activation of pyrimidine antimetabolites. The sensitivity of parental and TP expressing cells to 5-FU without or with TPI or LV was determined by the MTT assay (Table I) Table I . The sensitivity of parental and TP expressing cells to 5-FU without or with TPI, or LV. - (Fig. 3A) . We next examined 5-FU incorporation into RNA in AZ521 and AZ521/TP cells. As shown in Fig. 3B , TP did not affect the levels of [ 3 H]5-FU incorporated into RNA.
Expression level of TS. AZ521, AZ521/TP, KB and KB/TP cells were exposed to 0.1 μM 5-FU without or with 10 μM LV or 100 μM TPI, then the expression level of TS and the ternary complex of TS, FdUMP and LV were examined by immunoblot analysis (Fig. 4) . The expression level of TS in KB cells was higher than that of AZ521. .0001. After cells were incubated with or without 100 μM TPI overnight, the cells were exposed to 400 nM [performed RT-PCR using specific primers for TSP-1 and immunoblot analysis using an antibody against TSP-1. When KB/TP cells were treated with 5-FU, the expression levels of TSP-1 mRNA and TSP-1 protein were induced in KB/TP, but not in KB/CV cells (Fig/ 5B-D) .
The effect of LV and TPI on the induction of Egr-1 and TSP-1 by 5-FU.
We examined the expression of Egr-1 and TSP-1 in KB/TP cells treated with 5-FU in the presence or absence of LV. The Egr-1 level induced by 5-FU alone in KB/TP cells was higher than that in KB/CV cells. LV augmented the Egr-1 levels induced by 5-FU in both cell types. The expression of Egr-1 and TSP-1 mRNA in KB/TP cells treated with 5-FU in combination with LV was considerably higher than in KB/ CV cells treated with the same agents ( Fig. 6A  and B) . Furthermore, TPI suppressed the expression of Egr-1 and TSP-1 mRNA in KB/TP cells treated with 5-FU (Fig. 6C  and D) . We found that TP increased the sensitivity of AZ521 and KB cells to 5-FU, and TPI abrogated this effect of TP. TPI almost completely suppressed the formation of FdUMP and consequently the ternary complex in TP-expressing AZ521 and KB cells. However, TPI could not inhibit the incorporation of could be a predictive factor for the 5-FU cytotoxicity in vivo and in vitro (34) (35) (36) . These studies are in accordance with our findings that the cytotoxicity of 5-FU was enhanced by TP expression in AZ521 human gastric carcinoma cells and KB.
Advances based on delineation of the mechanisms of action of 5-FU demonstrated that LV can potentiate the antitumor activity of 5-FU (37, 38) . We showed that LV could potentiate the activity of 5-FU in TP-expressing AZ521/TP, but not in AZ521 cells. Expression of TP seems to be indispensable for the potentiating activity of LV. On the other hand, the sensitivity of KB/TP cells to 5-FU was about 5-fold increased by LV, but the difference in sensitivity was not significant. TS (EC 2.1.1.45), which converts deoxyuridine monophosphate (dUMP) to thymidylate, plays an essential role in the synthesis of DNA. Inhibition of TS by FdUMP is mediated by the formation of a stable ternary complex composed of FdUMP, TS, and the cofactor 5,10-methylenetetrahydrofolate (21, 22) . The ternary complex was detected in both TP expressing cells, and the interaction of TS with FdUMP was enhanced by LV in AZ521/TP cells, but not in KB/TP cells. This appears to be the reason why LV could not significantly increase the sensitivity to 5-FU of KB/TP cells. Further study is needed to elucidate why LV failed to augment the formation of the ternary complex. AZ521 cells were 93-fold more sensitive to 5-FU than KB cells. Some molecular bases for resistance to 5-FU have been identified. These mechanisms include amplification of TS and altered TS that is not inhibited by FdUMP (39, 40) . The TS level was reported to be controlled by an autoregulatory feedback mechanism wherein the TS protein interact with and controls the translational efficiency of its own mRNA (41) . Disruption of this autoregulatory loop by TS inhibitors leads to up-regulation of TS protein (42) . Carcinoma cells might become rapidly resistant to the cytotoxic effect of 5-FU by this mechanism. These results suggest that the increased expression level of TS is one of the important mechanisms of 5-FU-resistance. The expression level of TS in AZ521 cells was considerably lower than that in KB cells. This difference in TS level might explain the difference in sensitivity to 5-FU between AZ521 and KB cells. Our findings showed that TP is crucially involved in the reaction sequence that convert 5-FU to FdUMP, that is the principal cytotoxic metabolite of 5-FU in the TP expressing cells. The level of TS and the stable ternary complex seem to be related to response to 5-FU in the TP-expressing cells.
Recently, we found that 5-FU induced TSP-1 in human colon carcinoma KM12C cells (23) . A transcription factor, Egr-1, was also induced by 5-FU and bound to the promoter of TSP-1, enhancing its transcription and the subsequent production of TSP-1 protein. Moreover, we suggested that p38 mitogen-activated protein kinase (MAPK) plays an important role in 5-FU-induced EGR-1 transactivation. Egr-1 is a Cys2-His2 -typed zinc-finger transcription factor that has been implicated in the regulation of a number of genes involved in inflammation, differentiation, growth, and development (43) . It also regulates the expression of a diverse array of genes involved in tumor metastasis, including TSP-1, plasminogen activator inhibitor (PAI-1), and transforming growth factor-ß1 (TGF-ß1) (44, 45) . TSP-1 is a potent inhibitor of neovascularization that limits tumor growth and induces apoptosis and growth inhibition in neovascular endothelial cells (46) . Egr-1 possesses a strong inhibitory effect on the angiogenic activity of VEGF in vivo. High TSP-1 expression is also inversely correlated with invasive- ness and lymph node metastasis (47, 48) . Although FUTP was expressed in KB/CV at a level similar to that in KB/TP cells, both Egr-1 and TSP-1 were only slightly detected in KB/CV cells treated with 5-FU, if any. FUTP might not be implicated in the induction of Egr-1 and TSP-1 in KB/TP cells. Both Egr-1 and TSP-1 were detected in 5-FU-treated KB/TP cells that involve considerable amount of FdUMP converted from 5-FU by TP. TPI inhibited the TP activity and attenuated the expression of Egr-1 and TSP-1 mRNA, suggesting that TP activity is needed for the induction of Egr-1 and TSP-1 mRNA by 5-FU. On the other hand, LV that augmented the cytotoxic effect of FdUMP increased the expression of Egr-1 and TSP-1 mRNA. FdUMP blocks DNA synthesis and probably causes DNA strand bleakage. Cyclophosphamide, one of the alkylating agents, that seriously damages DNA molecule was previously reported to induce TSP-1 (49) . These findings together with our previous findings (23) suggest that TP is needed for the induction of Egr-1 and TSP-1 by 5-FU and the DNA damage by FdUMP caused the stress that activates p38 MAPK kinase pathway, and consequently induced Egr-1 and TSP-1 mRNA in the TPexpressing cells. Although further study is needed to elucidate whether Egr-1 and TSP-1 induction by 5-FU is implicated in the antitumor effect of 5-FU, our findings might be useful to develop new approaches for the treatment of TP-expressing tumors.
